226 related articles for article (PubMed ID: 33106225)
21. Impact of a VA-ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock-Design and Rationale of the ECMOsorb Trial.
Haertel F; Lehmann T; Heller T; Fritzenwanger M; Pfeifer R; Kretzschmar D; Otto S; Bogoviku J; Westphal J; Bruening C; Gecks T; Kaluza M; Moebius-Winkler S; Schulze PC
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568295
[TBL] [Abstract][Full Text] [Related]
22. Awake extracorporeal membrane oxygenation (ECMO) as bridge to recovery after left main coronary artery occlusion: a promising concept of haemodynamic support in cardiogenic shock.
Alozie A; Kische S; Birken T; Kaminski A; Westphal B; Nöldge-Schomburg G; Ince H; Steinhoff G
Heart Lung Circ; 2014 Oct; 23(10):e217-21. PubMed ID: 25043583
[TBL] [Abstract][Full Text] [Related]
23. Transfer of Patients With Cardiogenic Shock Using Veno-Arterial Extracorporeal Membrane Oxygenation.
Ali JM; Vuylsteke A; Fowles JA; Pettit S; Salaunkey K; Bhagra S; Lewis C; Parameshwar J; Kydd A; Patvardhan C; Jones N; Rubino A; Abu-Omar Y; Sudarshan C; Tsui S; Catarino P; Jenkins DP; Berman M
J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):374-382. PubMed ID: 31221511
[TBL] [Abstract][Full Text] [Related]
24. Predicting Parameters for Successful Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock.
Sawada K; Kawakami S; Murata S; Nishimura K; Tahara Y; Hosoda H; Nakashima T; Kataoka Y; Asaumi Y; Noguchi T; Sugimachi M; Fujita T; Kobayashi J; Yasuda S
ESC Heart Fail; 2021 Feb; 8(1):471-480. PubMed ID: 33264500
[TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial of ultra-protective vs. protective ventilation strategy in veno-arterial extracorporeal membrane oxygenation patients with refractory cardiogenic shock: a study protocol for the ultra-ECMO trial.
Li W; Chen C; Hu D; Sun F; Zhang G; Zhang Z; Dong Y; Lv J; Mei Y; Chen X
Front Cardiovasc Med; 2023; 10():1092653. PubMed ID: 37215539
[TBL] [Abstract][Full Text] [Related]
26. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support.
Sun T; Guy A; Sidhu A; Finlayson G; Grunau B; Ding L; Harle S; Dewar L; Cook R; Kanji HD
J Crit Care; 2018 Apr; 44():31-38. PubMed ID: 29040883
[TBL] [Abstract][Full Text] [Related]
27. VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.
Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
Artif Organs; 2019 Feb; 43(2):132-141. PubMed ID: 30402887
[TBL] [Abstract][Full Text] [Related]
28. Short-term and intermediate outcomes of cardiogenic shock and cardiac arrest patients supported by venoarterial extracorporeal membrane oxygenation.
Vakil D; Soto C; D'Costa Z; Volk L; Kandasamy S; Iyer D; Ikegami H; Russo MJ; Lee LY; Lemaire A
J Cardiothorac Surg; 2021 Oct; 16(1):290. PubMed ID: 34627305
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock.
Patel SM; Lipinski J; Al-Kindi SG; Patel T; Saric P; Li J; Nadeem F; Ladas T; Alaiti A; Phillips A; Medalion B; Deo S; Elgudin Y; Costa MA; Osman MN; Attizzani GF; Oliveira GH; Sareyyupoglu B; Bezerra HG
ASAIO J; 2019 Jan; 65(1):21-28. PubMed ID: 29489461
[TBL] [Abstract][Full Text] [Related]
30. The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis.
Kaddoura R; Omar AS; Ibrahim MIM; Alkhulaifi A; Lorusso R; Elsherbini H; Soliman O; Caliskan K
J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2483-2495. PubMed ID: 33583718
[TBL] [Abstract][Full Text] [Related]
31. Comparison of in-hospital outcomes of patients with vs. without ischaemic cardiomyopathy undergoing veno-arterial-extracorporeal membrane oxygenation.
Seong SW; Jin G; Kim M; Ahn KT; Yang JH; Gwon HC; Ko YG; Yu CW; Chun WJ; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Park SD; Cho SS; Ahn JH; Song PS; Jeong JO
ESC Heart Fail; 2021 Aug; 8(4):3308-3315. PubMed ID: 34145983
[TBL] [Abstract][Full Text] [Related]
32. Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
Russo JJ; Aleksova N; Pitcher I; Couture E; Parlow S; Faraz M; Visintini S; Simard T; Di Santo P; Mathew R; So DY; Takeda K; Garan AR; Karmpaliotis D; Takayama H; Kirtane AJ; Hibbert B
J Am Coll Cardiol; 2019 Feb; 73(6):654-662. PubMed ID: 30765031
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal membrane oxygenation support in acute coronary syndromes complicated by cardiogenic shock.
Esper SA; Bermudez C; Dueweke EJ; Kormos R; Subramaniam K; Mulukutla S; Sappington P; Waters J; Khandhar SJ
Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S45-50. PubMed ID: 25639707
[TBL] [Abstract][Full Text] [Related]
34. Optimal Timing of Venoarterial-Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Patients Suffering From Refractory Cardiogenic Shock.
Choi KH; Yang JH; Hong D; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Choi JH; Chung SR; Cho YH; Jeong DS; Sung K; Kim WS; Lee YT; Gwon HC
Circ J; 2020 Aug; 84(9):1502-1510. PubMed ID: 32684541
[TBL] [Abstract][Full Text] [Related]
35. Prognostic effect of estimated glomerular filtration rate in patients with cardiogenic shock or cardiac arrest undergoing percutaneous veno-arterial extracorporeal membrane oxygenation.
Kuroki N; Abe D; Iwama T; Sugiyama K; Akashi A; Hamabe Y; Aonuma K; Sato A
J Cardiol; 2016 Nov; 68(5):439-446. PubMed ID: 26611934
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Simultaneous Renal Replacement Therapy on Extracorporeal Membrane Oxygenation Support for Postcardiotomy Patients with Cardiogenic Shock: A Pilot Randomized Controlled Trial.
Li C; Wang H; Liu N; Jia M; Hou X
J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3063-3072. PubMed ID: 30928284
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
[No Abstract] [Full Text] [Related]
38. Initiation of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock during out of hours versus working hours is not associated with increased mortality.
van der Wal PS; Kraaijeveld AO; van der Heijden JJ; van Laake LW; Platenkamp M; de Heer LM; Braithwaite SA; van Eijk M; Hermens J; Cremer OL; Donker DW; Meuwese CL
Int J Artif Organs; 2022 Mar; 45(3):301-308. PubMed ID: 35139685
[TBL] [Abstract][Full Text] [Related]
39. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.
Schmidt M; Burrell A; Roberts L; Bailey M; Sheldrake J; Rycus PT; Hodgson C; Scheinkestel C; Cooper DJ; Thiagarajan RR; Brodie D; Pellegrino V; Pilcher D
Eur Heart J; 2015 Sep; 36(33):2246-56. PubMed ID: 26033984
[TBL] [Abstract][Full Text] [Related]
40. Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock.
Schrage B; Burkhoff D; Rübsamen N; Becher PM; Schwarzl M; Bernhardt A; Grahn H; Lubos E; Söffker G; Clemmensen P; Reichenspurner H; Blankenberg S; Westermann D
JACC Heart Fail; 2018 Dec; 6(12):1035-1043. PubMed ID: 30497643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
